Mar 09, 2023
Aldevron and Evanoa Sign Licensing Agreement
Mar 08, 2023
Texas Crop Science (TCS) and GDM Establish Strategic Collaboration to Develop Higher-Yielding Soybean Varieties for Soybean Farmers Globally
Mar 03, 2023
Bioceres Crop Solutions Announces Brazil´s Regulatory Approval of Drought Tolerant HB4® Wheat for Commercialization and Cultivation
Feb 24, 2023
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
Feb 22, 2023
Kite Completes Acquisition of Tmunity
Feb 22, 2023
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions
Feb 17, 2023
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
Feb 16, 2023
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company
Feb 09, 2023
DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration
Feb 09, 2023
Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results
Jan 31, 2023
X-Chem and Kymera Expand Existing Partnership
Jan 19, 2023
VectorY and Annogen Announce Research Collaboration for the Development of CNS-cell Specific Promoters
Jan 19, 2023
Kaneka expands GMP manufacturing capacity for mRNA in Kaneka Eurogentec S.A.
Jan 17, 2023
TTP Introduces Cellular Origins, a TTP Company Focussed on Delivering Scalable Manufacture of Cell and Gene Therapies
Jan 14, 2023
Breakthrough CRISPR Technology Study Published in Nature
Jan 10, 2023
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
Jan 10, 2023
DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by TRICARE
Jan 09, 2023
Athersys Provides MultiStem Clinical Update
Jan 06, 2023
Therapeutic Drug Monitoring Global Market Report 2023: Increasing Demand for Genetic Testing Bolsters Sector - ResearchAndMarkets.com
Dec 20, 2022
KBI Biopharma, Inc. Secures Swissmedic Regulatory Establishment License for State-of-the-Art Mammalian Cell Manufacturing Facility in Geneva